Jump to content

Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Dasatinib Could Increase Risk for Pulmonary Hypertension.

  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,547 posts
  • Location:West Sussex

Posted 08 February 2012 - 12:54 PM

Dasatinib Could Increase Risk for Pulmonary Hypertension.

The FDA has warned that dasatinib (Sprycel, Bristol-Myers Squibb) may increase the risk for pulmonary arterial hypertension (PAH). Dasatinib is used to treat certain types of leukemia, and is sometimes used off-label for other cancers. TheHeart.org, Dec. 2012. (Also see: Causes of Pulmonary Hypertension)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)